Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
ECI Pharmaceuticals
ECI Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Trientine
Trientine
2021-08-13
Hepatolenticular degeneration
,
Nervous system heavy metal poisoning
Xtrelus
Guaifenesin
,
Hydrocodone
2018-04-25
2025-2035
Pain
,
Fever
,
Postoperative pain
,
Obstructive lung diseases
,
Cough
,
Inflammation
,
Juvenile arthritis
,
Menorrhagia
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Osteoarthritis
,
Bursitis
,
Dysmenorrhea
,
Gout
,
Premenstrual syndrome
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Obesity
,
Urinary incontinence
,
Rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Rheumatic fever
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use